21 web-programmer-developer-"LIST"-"https:"-"https:"-"https:" Postdoctoral positions at University of Lund
Sort by
Refine Your Search
-
Description of the workplace The Department of Immunotechnology conducts research ranging from advanced technology development to biomedical studies. The main research areas include sensitization
-
. 100–800 CE). This is achieved by using the latest generation of digital tools and techniques in archaeology. The project has aimed to develop a two-part research programme. The first part focuses
-
: The application should include a well-developed research plan describing their proposed area of research within the broader scope of the project. The plan should clearly articulate the intended focus, the theories
-
include a well-developed research plan describing their proposed area of research within the broader scope of the project. The plan should clearly articulate the intended focus, the theories and methods
-
, graph theory and more to characterize biomolecular systems. The project is predominantly an applied project focusing on protein characterization; however, there is a possibility for method development
-
. The postdoctoral scholar will take a leading role in the the BeeSYNC project, focusing specifically on: Computational Natural History. The researcher will develop deep learning models to predict individual bee age
-
should be written in English and is to include: a CV, copy of your doctoral degree certificate, list of publications, a research plan, up to five publications and a pedagogical statement. Your research
-
collaborative activities, such as publications, conferences, and workshops. The position is a career development post, and its purpose is to act as an initial step on a career path by providing the opportunity
-
outside Europe. Collect and analyze high-quality data. Develop your own research questions within the framework of the project. Participate in regular project meetings and collaborate closely with other
-
consists in you independently developing in vivo reprogramming of tumor cells into cDC1-like cells using RNA vectors, with the ultimate goal to develop an off-the-shelf, safe, and scalable immunotherapy